Cargando…
Mesenchymal Stem Cells cause Telomere Length Reduction of Molt-4 Cells via Caspase-3, BAD and P53 Apoptotic Pathway
Mesenchymal stem cells (MSCs) as undifferentiated cells are specially considered in cell-based cancer therapy due to unique features such as multi-potency, pluripotency, and self-renewal. A multitude of cytokines secreted from MSCs are known to give such multifunctional attributes, but details of th...
Autores principales: | Heidari, Hamid Reza, Fathi, Ezzatollah, Montazersaheb, Soheila, Mamandi, Ayoub, Farahzadi, Raheleh, Zalavi, Soran, Nozad Charoudeh, Hojjatollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496249/ https://www.ncbi.nlm.nih.gov/pubmed/34703795 http://dx.doi.org/10.22088/IJMCM.BUMS.10.2.113 |
Ejemplares similares
-
Mesenchymal stem cells promote caspase-3 expression of SH-SY5Y neuroblastoma cells via reducing telomerase activity and telomere length
por: Fathi, Ezzatollah, et al.
Publicado: (2021) -
Interleukin-6, -8, and TGF-β Secreted from Mesenchymal Stem Cells Show Functional Role in Reduction of Telomerase Activity of Leukemia Cell Via Wnt5a/β-Catenin and P53 Pathways
por: Fathi, Ezzatollah, et al.
Publicado: (2020) -
Targeting the stem cell niche micro-environment as therapeutic strategies in aging
por: Farahzadi, Raheleh, et al.
Publicado: (2023) -
Cellular and Molecular Mechanisms Involved in Hematopoietic Stem Cell Aging as a Clinical Prospect
por: Montazersaheb, Soheila, et al.
Publicado: (2022) -
Potential of Peptide Nucleic Acids in Future Therapeutic Applications
por: Montazersaheb, Soheila, et al.
Publicado: (2018)